+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID07588425

Observational Study of Cardiac Effects in Women Receiving Systemic Therapy for Early-Stage Breast Cancer

Led by Fatih GURLER · Updated on 2026-09-16

100

Participants Needed

1

Research Sites

15 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating cardiac side effects in women with early-stage breast cancer who receive systemic chemotherapy andor anti-HER2 therapy as part of their usual cancer care. The study aims to determine if changes in Global Longitudinal Strain GLS on echocardiography can detect early heart dysfunction before a drop in left ventricular ejection fraction LVEF. It also investigates whether changes in circulating microRNA levels relate to early cardiac dysfunction and if cardiotoxicity occurs more often with anthracycline-containing chemotherapy compared to anthracycline-free treatments. Participants receive standard chemotherapy andor anti-HER2 therapy as determined by their oncologist. The study does not alter treatment selection, dose, or duration. Patients are grouped by chemotherapy regimen for comparison. Assessments occur at four time points before treatment, and at 3, 6, and 12 months after starting therapy. These include echocardiography measuring LVEF, GLS, and other heart function parameters, blood samples for microRNA and cardiac biomarker analysis, and quality of life questionnaires. Participants undergo transthoracic echocardiography and blood draws aligned with their routine care visits, providing samples for microRNA and cardiac biomarker testing. They complete various patient-reported outcome questionnaires assessing quality of life, fatigue, sexual health, anxietydepression, sleep quality, and cognitive function. The study monitors adverse events and tracks cardiac dysfunction incidence over 12 months to better understand early cardiac effects and identify patients at higher risk during systemic breast cancer treatment.

CONDITIONS

Brief Title

Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer

Research Team

S

Sıla Soylu Koçoğlu, MD

F

Fatih Gürler, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here